/
© 2026 RiffOn. All rights reserved.
  1. The Private Equity Podcast, by Raw Selection
  2. The journey from $140M to a $1Bn Valuation and a stage 4 cancer victory
The journey from $140M to a $1Bn Valuation and a stage 4 cancer victory

The journey from $140M to a $1Bn Valuation and a stage 4 cancer victory

The Private Equity Podcast, by Raw Selection · Jan 6, 2026

CEO Mark Adams shares his journey from a stage 4 cancer victory to creating a unique model that grows business valuations from $140M to $1Bn.

Half of Strategic Acquirers Prefer Buying Businesses with Room for Improvement

Counterintuitively, making a business hyper-efficient before a sale is not always optimal. Roughly half of buyers prefer acquiring companies with identifiable inefficiencies because improving them is a key part of their own value-creation thesis and justification for the acquisition.

The journey from $140M to a $1Bn Valuation and a stage 4 cancer victory thumbnail

The journey from $140M to a $1Bn Valuation and a stage 4 cancer victory

The Private Equity Podcast, by Raw Selection·a month ago

80-90% of SMEs Under $75M in Revenue Are Priced Too High to Ever Sell

A vast majority of small-to-medium enterprises are priced at valuations their market will not support. This market failure means 8 or 9 out of 10 of these businesses never get sold, trapping their owners—often Baby Boomers—into working long past their desired retirement age.

The journey from $140M to a $1Bn Valuation and a stage 4 cancer victory thumbnail

The journey from $140M to a $1Bn Valuation and a stage 4 cancer victory

The Private Equity Podcast, by Raw Selection·a month ago

Top Acquirers Adapt Their Processes to New Companies, Not the Other Way Around

Successful large-scale acquirers remain nimble, flexing their own processes to suit the acquired company rather than force-fitting it into a rigid corporate structure. This preserves the culture and talent that made the company valuable, preventing value destruction and keeping the new team engaged.

The journey from $140M to a $1Bn Valuation and a stage 4 cancer victory thumbnail

The journey from $140M to a $1Bn Valuation and a stage 4 cancer victory

The Private Equity Podcast, by Raw Selection·a month ago

Private Equity Firms Lose Value by Limiting Engagement to the Boardroom

PE investors often fail to unlock a portfolio company's full potential by only interacting at the board level. Engaging deeper with operational leadership is crucial to understand the team's true quality and identify opportunities to transform the value proposition, which are often missed from the boardroom.

The journey from $140M to a $1Bn Valuation and a stage 4 cancer victory thumbnail

The journey from $140M to a $1Bn Valuation and a stage 4 cancer victory

The Private Equity Podcast, by Raw Selection·a month ago

Business Owners Lose 30-50% of Their Sale Price to Fees and Taxes

When selling a business, owners often underestimate the impact of fees and taxes. Across professional services (lawyers, accountants) and taxes, 93% of owners lose between 30% and 50% of the final sticker price, with the exact amount varying significantly by geography (e.g., California vs. the UK).

The journey from $140M to a $1Bn Valuation and a stage 4 cancer victory thumbnail

The journey from $140M to a $1Bn Valuation and a stage 4 cancer victory

The Private Equity Podcast, by Raw Selection·a month ago

Aggressive Post-Acquisition Integration Risks Losing Unquantifiable Soft Skills

Due diligence cannot quantify a team's crucial soft skills. When an acquirer forces change aggressively post-close, they risk an exodus of these skills and key talent, maximizing the chance of the investment failing. A partnership approach that preserves talent for at least the first year is a much safer strategy.

The journey from $140M to a $1Bn Valuation and a stage 4 cancer victory thumbnail

The journey from $140M to a $1Bn Valuation and a stage 4 cancer victory

The Private Equity Podcast, by Raw Selection·a month ago

Transform Valuations by Repositioning Low-Value Products as High-Ticket Items

Exponential valuation growth often comes from fundamentally repositioning a product to command a much higher price, not just increasing sales volume. This strategy, which multiplied one company's sale value by over 100x, requires deep market understanding to turn a low-value proposition into a high-ticket one.

The journey from $140M to a $1Bn Valuation and a stage 4 cancer victory thumbnail

The journey from $140M to a $1Bn Valuation and a stage 4 cancer victory

The Private Equity Podcast, by Raw Selection·a month ago

Acquisitions For You's Framework Doubles Value Without Owner Dilution or Debt

A unique "Double and Keep It" model helps business owners double their company's value by using external capital from family offices to acquire other companies. This creates a larger, more attractive group for a future sale, increasing the owner's payout without them taking equity dilution or adding debt to their original business.

The journey from $140M to a $1Bn Valuation and a stage 4 cancer victory thumbnail

The journey from $140M to a $1Bn Valuation and a stage 4 cancer victory

The Private Equity Podcast, by Raw Selection·a month ago